In Vitro Diagnostics Companies Embrace Molecular Diagnostics for Better Healthcare – By PMI

Prophecy Market Insights latest research report on the In Vitro Diagnostics Market provides a comprehensive analysis of the current market scenario, growth opportunities, challenges, and emerging trends. The report offers insights into the market's size and share, key market players, distribution channels, and consumer preferences. It also examines the impact of the COVID-19 pandemic on the market and provides a detailed analysis of the competitive landscape, including strategic alliances, mergers, and acquisitions.

Covina, Oct. 12, 2023 (GLOBE NEWSWIRE) -- In-Vitro Diagnostics (IVD) are medical devices used for monitoring, diagnosing, screening and assessing predisposition of diseases from test-tube assays outside an organism. Cancer screening, HIV tests, self-test for pregnancy, blood type identification and blood glucose monitoring for diabetes are some examples of IVD products.

Improved healthcare infrastructure and growing demand for medical devices has boost the demand for In Vitro Diagnostics market growth. New partnerships with pharmaceutical and biotechnology companies have enabled players to fuel the rapid growth of capabilities and capacities by helping industries succeed in medical devices production.

Key Highlights:

  • In Februay 2023, Mylab Discovery Solution rolled out new IVD (in vitro diagnostic) medical devices and kits range for empowering small labs across the country. The new range of IVD devices and reagents are designed for physicians, small to medium size laboratories to perform diagnoses at their facilities.

Click Here to Get PDF Brochure of this Report:

Analyst View:
The ongoing advancements in the field of gene & immunoassay based products and continuous commercialization of innovative diagnostic products coupled with the recent discovery of genetic biomarkers & their clinical role in immunoassay testing has powered the demand for In Vitro Diagnostics market growth.

Report Scope:

Base year for estimation2022
Forecast period2022 – 2032
Market representationRevenue in USD Billion & CAGR from 2022 to 2032
Market SegmentationBy Product & Services – Reagents, Instruments, and Services
By Technology - Hematology, Immunoassay, Molecular Diagnostics, Microbiology, Clinical Chemistry, Coagulation, and Others
By Application - Oncology, Diabetes, Cardiology, Infectious Disease, Nephrology, Drug Testing, Autoimmune Disease and Others
By End-Users - Hospital Laboratories, Point of Care, Home Care, Clinical Laboratories, and Others
Regional scopeNorth America - U.S., Canada
Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe
Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
Latin America - Brazil, Mexico, Argentina, Rest of Latin America
Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverageRevenue forecast, company share, competitive landscape, growth factors, and trends

Key players:

  • Abbott
  • Qiagen
  • Agilent Technologies Inc
  • bioMerieux SA
  • Siemens Healthineers
  • Sysmex Corp
  • Danaher Corporation
  • F-Hoffman-La Roche Ltd
  • Charles River Laboratories
  • Becton Dickinson and Company

Ask for a sample copy of this report at

Market Growth:

  • Rising Demand for Precision Medicine: The IVD market has seen substantial growth due to the increasing focus on precision medicine. Personalized diagnostics and treatments are becoming more common, driving demand for advanced IVD technologies.
  • Advancements in Technology: Technological innovations, such as molecular diagnostics, point-of-care testing, and the integration of artificial intelligence, have transformed the IVD landscape, leading to improved diagnostic accuracy and efficiency.
  • Global Health Challenges: The COVID-19 pandemic has highlighted the importance of IVD in addressing global health crises. Rapid diagnostic tests and PCR-based diagnostics played a critical role in managing the pandemic, further boosting the IVD market.
  • Growing Chronic Disease Burden: The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and cancer has led to an increased need for early diagnosis and monitoring, driving the demand for IVD solutions.
  • Emerging Markets: Emerging economies are witnessing a surge in demand for IVD products and services due to expanding healthcare infrastructure, increasing healthcare expenditure, and a growing middle-class population.

Future outlook:

  • Technological Advancements: Continued innovation in IVD technologies will drive market growth. Advancements in molecular diagnostics, such as next-generation sequencing (NGS) and gene editing, are expected to play a significant role in diagnostics and treatment selection.
  • Artificial Intelligence (AI) and Data Analytics: AI and machine learning are being increasingly integrated into IVD platforms to improve data analysis and diagnostic accuracy. AI-driven algorithms can assist in interpreting complex medical data and identifying patterns for more precise diagnoses.
  • Point-of-Care Testing (POCT): POCT devices are becoming more sophisticated, enabling rapid and accurate diagnostics at the point of care. These devices are expected to gain wider acceptance for their role in remote and underserved areas, as well as in emergencies and disaster response.
  • Home Testing Kits: The popularity of home-based diagnostic testing is expected to continue growing, especially for monitoring chronic conditions and for early disease detection. The convenience of self-testing will drive demand for such products.
  • Personalized Medicine: The IVD industry will play a critical role in the development of personalized treatment plans. Genetic and molecular diagnostics will help tailor medical interventions to an individual's unique genetic makeup and health profile.

Browse More Related Reports:

  1. Diagnostic Labs Market
  2. Preimplantation Genetic Testing Market
  3. Oncology Molecular Diagnostics Market


Follow us on:

LinkedIn | Twitter | Facebook |YouTube


Contact Data